Clinical Decision and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

  • STATUS
    Recruiting
  • End date
    Dec 31, 2025
  • participants needed
    1
  • sponsor
    Ping Liang
Updated on 16 March 2022
cancer

Summary

Developing a deep learning model based on contrast-enhanced ultrasound (CEUS) to predict the prognosis of hepatocellular carcinoma (HCC) and aid choose operation decisions

Description

Collecting CEUS and clinical data of HCC from different institutions retrospectively.

Developing a deep learning model based on CEUS to predict the prognosis of HCC. Developing a deep learning model based on CEUS to choose a better operation (ablation or surgery) of HCC patients.

Then, validating the deep learning model in the prospective data.

Details
Condition Hepatocellular Carcinoma, Contrast-enhanced Ultrasound, Prognosis, Surgery, Ablation
Treatment Surgery
Clinical Study IdentifierNCT05257694
SponsorPing Liang
Last Modified on16 March 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

patients with HCC (Ia, Ib, IIa stage) China liver cancer staging who underwent resection or ablation
without macro-vascular invasion
Child-Pugh A/B grade
HCC is proved by pathological examination or two enhanced imaging
CEUS (Sonovue or Sonozoid) images are performed two weeks before the operation
CEUS images are included in at least three stages (Arterial phase, Portal phase, and Late phase)

Exclusion Criteria

postop follow-up loss or expired less than 3 months
patients with co-malignancy
poor images quality for analyzing
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note